Mike Waring
Newcastle University
Biography
Mike Waring is Chair of Medicinal ÉîÒ¹¸£Àû¹ú²ú¾«Æ· at Newcastle University and Head of ÉîÒ¹¸£Àû¹ú²ú¾«Æ· for the Cancer Research UK Newcastle Drug Discovery Unit. He was previously Principal Scientist in Medicinal ÉîÒ¹¸£Àû¹ú²ú¾«Æ· at AstraZeneca. He has worked mainly in the areas of diabetes and oncology and his work has contributed to the discovery of 14 drug candidates, including the marketed EGFR inhibitor osimertinib (Tagrissoâ„¢).
He has made significant contributions to the field in many areas, perhaps most notably property-based optimisation, covalent inhibition, novel binding modes and new methods of hit generation. He is a 2018 American Chemical Society Hero of ÉîÒ¹¸£Àû¹ú²ú¾«Æ· and recipient of the 2017 RSC Malcolm Campbell Medal. He is an elected fellow of the Royal Society of ÉîÒ¹¸£Àû¹ú²ú¾«Æ·.
RSC affiliations
Editor-in-Chief, RSC Medicinal ÉîÒ¹¸£Àû¹ú²ú¾«Æ·
Contact Mike Waring
UK